MTP pain. M77.4
Conditions
Interventions
Intervention 1: Intervention group:In this group of 40mg of methyl prednisolone from the Abouiryhan Pharmaceutical Company for injection into metatarsophalangeal joint is used in the first visit under
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: At least 18 years old A history of MTP pain during rest or walking that lasts for at least 3 months. Having a VAS score of at least 3 before entering the study Pain at the dorsal of the first MTP Radiographic evidence of OA as a reduction in articular space or formation of steophyte (grade 1.2)
Exclusion criteria
Exclusion criteria: Patient's willingness to leave the study at each stage of the plan Lack of access to the patient for post-intervention examination due to lack of personal referral The patient's desire to use systemic steroid or intra-articular injection, except for the injectable substance studied by the patient during the study period Radiographic evidence of severe osteoarthritis (grade 3) Previous history of MTP surgery History of any MTP injections within the past six months Use of modality in physiotherapy in the last 3 months Do not have the ability to walk for daily routine (> 50 m) without the assistive device. There is a risk factor for intra-articular injection such as anticoagulant Presence of poor control diabetes, coagulation disorders, fractures, rheumatologic diseases, tumors and infections and gout Pregnancy or the decision to become pregnant Severe deformity of the MTP joint Acute trauma (last 3 months)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: The beginning of the study and 6-2 weeks after the injection. Method of measurement: VAS questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Score patient status. Timepoint: In the beginning of the study, and 2-6 weeks after the injection of the drug. Method of measurement: American Orthopedic Foot and Ankle Society Score (AOFAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Emami Razavi
Tehran University of Medical Sciences
Outcome results
None listed